Showing results (341-350 of 538) with videos related to

Sort By:
Pageof 54
Headache|July 1, 2020
Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative ReviewRami Burstein, Andrew M Blumenfeld, Stephen D Silberstein, et al.
Neurology|June 24, 2016
The migraine postdrome: An electronic diary studyNicola J Giffin, Richard B Lipton, Stephen D Silberstein, et al.
Journal of Neurology|November 8, 2012
Psychiatric comorbidities of episodic and chronic migraineDawn C Buse, Stephen D Silberstein, Aubrey N Manack, et al.
The Journal of Headache and Pain|December 29, 2019
Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)Stephen D Silberstein, Virginia L Stauffer, Katie A Day, et al.
Headache|January 24, 2009
Migraine in the triptan era: lessons from epidemiology, pathophysiology, and clinical scienceMarcelo E Bigal, Michel Ferrari, Stephen D Silberstein, et al.
Headache|October 31, 2018
Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for MigraineStephen D Silberstein, Lulu Lee, Kavita Gandhi, et al.
Headache|April 19, 2006
Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled studyJerome Goldstein, Stephen D Silberstein, Joel R Saper, et al.
Headache|October 3, 2021
Intravenous ibuprofen for acute treatment of migraine: A double-blind, randomized, placebo-controlled pilot studyHsiangkuo Yuan, John G Curran, Scott W Keith, et al.
Headache|July 10, 2024
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trialsStephen D Silberstein, Hans-Christoph Diener, David W Dodick, et al.
Headache|June 27, 2024
Clinical factors associated with day-to-day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary dataMarina Vives-Mestres, Amparo Casanova, Stephen D Silberstein, et al.
Pageof 54